ログイン

HEMATOLOGY

HEMATOLOGY
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    The ? test is a diagnostic procedure. Flow cytometry is becoming more commonly used because it is more specific and sensitive than THIS

    sucrose hemolysis (sugar-water)

  • 2

    The sucrose hemolysis (sugar-water) test is a diagnostic procedure. ? is becoming more commonly used because it is more specific and sensitive than the sucrose lysis test

    Flow cytometry

  • 3

    2 ASSOCIATED syndrome OF Acanthocytosis

    Abetalipoproteinemia and McLeod syndrome

  • 4

    Abetalipoproteinemia and McLeod syndrome

    Acanthocytosis

  • 5

    what def Decreased surface to volume, No central pallor, Decreased resistance to hypotonic saline, and decreased deformability

    Hereditary spherocytosis

  • 6

    Hereditary spherocytosis is an _________ hemolysis

    Extravascular

  • 7

    is an Extravascular hemolysis

    Hereditary spherocytosis

  • 8

    is a membrane defect characterized by a spectrin abnormality and thermal instability. The MCV is decreased and the red cells appear to be budding and fragmented

    Hereditary pyropoikilocytosis

  • 9

    Hereditary pyropoikilocytosis is a membrane defect characterized by a spectrin abnormality and thermal instability. The MCV is ? and the red cells appear to be budding and fragmented

    decreased

  • 10

    Hereditary pyropoikilocytosis is a membrane defect characterized by a spectrin abnormality and thermal instability. The MCV is decreased and the red cells appear to be ? and ?

    budding and fragmented

  • 11

    Decreased Osmotic fragility: (3)

    Sickle cell anemia, target cells, and other poikilocytes

  • 12

    cause of?: Sickle cell anemia, target cells, and other poikilocytes

    Decreased Osmotic fragility

  • 13

    Sickle cell 2 hemolysis

    1. Initial hemolysis 2. Complete hemolysis

  • 14

    Sickle cell Initial hemolysis NaCl

    0.35% NaCl

  • 15

    Sickle cell 0.35% NaCl

    Initial hemolysis

  • 16

    Sickle cell Complete hemolysis NaCl

    0.20%

  • 17

    Sickle cell 0.20% NaCl

    Complete hemolysis

  • 18

    result: Autohemolysis test Glucose-6-phosphate dehydrogenase (G6PD) def, Hereditary spherocytosis (HS), Pyruvate kinase (PK) deficiency

    Positive Autohemolysis test

  • 19

    Positive Autohemolysis test

    Glucose-6-phosphate dehydrogenase (G6PD) def, Hereditary spherocytosis (HS), Pyruvate kinase (PK) deficiency

  • 20

    a general term used to denote an increased variation in cell size

    Anisocytosis

  • 21

    -visualize with supravital stain but not wright stain

    Heinz bodies

  • 22

    Heinz bodies -visualize with ? stain but not wright stain

    supravital

  • 23

    Heinz bodies -visualize with supravital stain but not ?

    wright stain

  • 24

    Nuclear remnants of DNA

    Howell Jolly bodies

  • 25

    Howell Jolly bodies Nuclear remnants of

    DNA

  • 26

    Autoimmune hemolytic anemia is best characterized by ___________

    Spherocytes

  • 27

    ? is best characterized by Spherocytes

    Autoimmune hemolytic anemia

  • 28

    Autoagglutination at room temperature may cause a ____ RBC count and ___ MCV from an electronic counter

    Low, High

  • 29

    ? at room temperature may cause a Low RBC count and High MCV from an electronic counter

    Autoagglutination

  • 30

    Findings in Hemolytic Uremic Syndrome (HUS)

    Thrombocytopenia Schistocyte polychromasia -Hemoglobinuria Hemorrhage ,

  • 31

    Findings in ? -Hemorrhage , -Thrombocytopenia, -Hemoglobinuria, -Schistocyte -polychromasia

    Hemolytic Uremic Syndrome (HUS)

  • 32

    Supreme filter of the body

    Spleen

  • 33

    Removal of senescent RBC

    Culling

  • 34

    Removal of Cell inclusion

    Pitting

  • 35

    ? membrane integrity is not destroyed in pitting

    RBC

  • 36

    _______ is not associated to intravascular hemolysis

    Methemoglobinemia

  • 37

    most valuable and reliable criterion ID of mature and immature WBC

    Nuclear chromatin pattern

  • 38

    MATURATION STORAGE % metamyelocytes

    45

  • 39

    MATURATION STORAGE 45%

    metamyelocytes

  • 40

    MATURATION STORAGE 35%

    BAND FORM NEUTROPHILS

  • 41

    MATURATION STORAGE % BAND FORM NEUTROPHILS

    35

  • 42

    MATURATION STORAGE 20%

    SEGMENTED NEUTROPHILS

  • 43

    MATURATION STORAGE % SEGMENTED NEUTROPHILS

    20

  • 44

    myelocytes DAYS

    4.3 DAYS

  • 45

    4.3 DAYS

    myelocytes

  • 46

    15 HOURS

    MYELOBLASTS

  • 47

    MYELOBLASTS TIME

    15 HOURS

  • 48

    24 HOURS

    PROMYELOCYTES

  • 49

    PROMYELOCYTES HOURS

    24

  • 50

    % PROGENITOR CELLS

    0.1- 0.2

  • 51

    0.1- 0.2% ? CELLS

    PROGENITOR CELLS

  • 52

    1% ?

    MYELOBLASTS

  • 53

    % MYELOBLASTS

    1

  • 54

    3%

    PROMYELOCYTES

  • 55

    ?% PROMYELOCYTES

    3

  • 56

    -Spongy/foamy cytoplasm

    Myeloblast

  • 57

    Myeloblast -appearance? cytoplasm

    Spongy/foamy

  • 58

    --sieve-like nucleus

    Myeloblast

  • 59

    Myeloblast --?-like nucleus

    sieve

  • 60

    Contains primary specific granules

    Promyelocyte

  • 61

    Promyelocyte Contains ? specific granules

    primary

  • 62

    Lymphocytes don’t have ______

    Myeloperoxidase

  • 63

    ? don’t have Myeloperoxidase

    Lymphocytes

  • 64

    Secondary granules

    Myelocyte

  • 65

    Myelocyte ? granules

    Secondary

  • 66

    -1st stage where granulocytes can be differentiated

    Myelocyte

  • 67

    Once the metamyelocyte stage has been reached, cells have undergone _____ division the the proliferation phase comes to an end

    4 or 5

  • 68

    Once the ? stage has been reached, cells have undergone 4 or 5 division the the proliferation phase comes to an end

    metamyelocyte

  • 69

    -Predominant WBC precursor in the bone marrow

    Metamyelocyte/Juvenile cells

  • 70

    Metamyelocyte/? cells

    Juvenile

  • 71

    /Juvenile cells

    Metamyelocyte

  • 72

    -Tertiary granules

    Metamyelocyte/Juvenile cells

  • 73

    Metamyelocyte/Juvenile cells -? granules

    Tertiary

  • 74

    First immature WBC seen in the blood

    Band cell

  • 75

    Basophil stay in the maturation-storage phase for ____ hrs

    12

  • 76

    ? stay in the maturation-storage phase for 12 hrs

    Basophil

  • 77

    is a hallmark of allergic disorders

    eosinophilia

  • 78

    eosinophilia is a hallmark of ? disorders

    allergic

  • 79

    Not true WBC

    Mast cell

  • 80

    cells in Humoral immunity

    B cell

  • 81

    B celL ? immunity

    Humoral

  • 82

    Cellular immunity

    T and Nk Cell

  • 83

    ? immunity : T and Nk Cell

    Cellular

  • 84

    B cells with hair like projection which are identified by being TRAP resistance

    Hairy cell

  • 85

    Hairy cell : B cells with hair like projection which are identified by being ? resistance

    TRAP

  • 86

    Mononuclear cell with a cerebriform nucleus

    Sezary cell

  • 87

    Deeply basophilic cytoplasm with eccentric nucleus

    Plasma cell

  • 88

    Hyposegmentation/

    Pelger-huet

  • 89

    pince nez

    Pelger-huet

  • 90

    dumb bell

    Pelger-huet

  • 91

    peanut shape

    Pelger-huet

  • 92

    spectacle like

    Pelger-huet

  • 93

    Large platelet with Dohle-like

    May heglin

  • 94

    May heglin ? platelet with Dohle-like

    Large

  • 95

    May heglin : Large platelet with ? -like

    Dohle

  • 96

    Increased LAP score

    Leukemoid reaction

  • 97

    Leukemoid reaction ? LAP score

    Increased

  • 98

    Markedly decreased LAP

    CML

  • 99

    CML Markedly ? LAP

    decreased

  • 100

    There is a relative ? in children from ages 4 months to 4 years Because of this, the percentage of lymphocytes is increased in this population. This is commonly referred to as a reversal in the normal differential percentage (or inverted differential)

    neutropenia

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    The ? test is a diagnostic procedure. Flow cytometry is becoming more commonly used because it is more specific and sensitive than THIS

    sucrose hemolysis (sugar-water)

  • 2

    The sucrose hemolysis (sugar-water) test is a diagnostic procedure. ? is becoming more commonly used because it is more specific and sensitive than the sucrose lysis test

    Flow cytometry

  • 3

    2 ASSOCIATED syndrome OF Acanthocytosis

    Abetalipoproteinemia and McLeod syndrome

  • 4

    Abetalipoproteinemia and McLeod syndrome

    Acanthocytosis

  • 5

    what def Decreased surface to volume, No central pallor, Decreased resistance to hypotonic saline, and decreased deformability

    Hereditary spherocytosis

  • 6

    Hereditary spherocytosis is an _________ hemolysis

    Extravascular

  • 7

    is an Extravascular hemolysis

    Hereditary spherocytosis

  • 8

    is a membrane defect characterized by a spectrin abnormality and thermal instability. The MCV is decreased and the red cells appear to be budding and fragmented

    Hereditary pyropoikilocytosis

  • 9

    Hereditary pyropoikilocytosis is a membrane defect characterized by a spectrin abnormality and thermal instability. The MCV is ? and the red cells appear to be budding and fragmented

    decreased

  • 10

    Hereditary pyropoikilocytosis is a membrane defect characterized by a spectrin abnormality and thermal instability. The MCV is decreased and the red cells appear to be ? and ?

    budding and fragmented

  • 11

    Decreased Osmotic fragility: (3)

    Sickle cell anemia, target cells, and other poikilocytes

  • 12

    cause of?: Sickle cell anemia, target cells, and other poikilocytes

    Decreased Osmotic fragility

  • 13

    Sickle cell 2 hemolysis

    1. Initial hemolysis 2. Complete hemolysis

  • 14

    Sickle cell Initial hemolysis NaCl

    0.35% NaCl

  • 15

    Sickle cell 0.35% NaCl

    Initial hemolysis

  • 16

    Sickle cell Complete hemolysis NaCl

    0.20%

  • 17

    Sickle cell 0.20% NaCl

    Complete hemolysis

  • 18

    result: Autohemolysis test Glucose-6-phosphate dehydrogenase (G6PD) def, Hereditary spherocytosis (HS), Pyruvate kinase (PK) deficiency

    Positive Autohemolysis test

  • 19

    Positive Autohemolysis test

    Glucose-6-phosphate dehydrogenase (G6PD) def, Hereditary spherocytosis (HS), Pyruvate kinase (PK) deficiency

  • 20

    a general term used to denote an increased variation in cell size

    Anisocytosis

  • 21

    -visualize with supravital stain but not wright stain

    Heinz bodies

  • 22

    Heinz bodies -visualize with ? stain but not wright stain

    supravital

  • 23

    Heinz bodies -visualize with supravital stain but not ?

    wright stain

  • 24

    Nuclear remnants of DNA

    Howell Jolly bodies

  • 25

    Howell Jolly bodies Nuclear remnants of

    DNA

  • 26

    Autoimmune hemolytic anemia is best characterized by ___________

    Spherocytes

  • 27

    ? is best characterized by Spherocytes

    Autoimmune hemolytic anemia

  • 28

    Autoagglutination at room temperature may cause a ____ RBC count and ___ MCV from an electronic counter

    Low, High

  • 29

    ? at room temperature may cause a Low RBC count and High MCV from an electronic counter

    Autoagglutination

  • 30

    Findings in Hemolytic Uremic Syndrome (HUS)

    Thrombocytopenia Schistocyte polychromasia -Hemoglobinuria Hemorrhage ,

  • 31

    Findings in ? -Hemorrhage , -Thrombocytopenia, -Hemoglobinuria, -Schistocyte -polychromasia

    Hemolytic Uremic Syndrome (HUS)

  • 32

    Supreme filter of the body

    Spleen

  • 33

    Removal of senescent RBC

    Culling

  • 34

    Removal of Cell inclusion

    Pitting

  • 35

    ? membrane integrity is not destroyed in pitting

    RBC

  • 36

    _______ is not associated to intravascular hemolysis

    Methemoglobinemia

  • 37

    most valuable and reliable criterion ID of mature and immature WBC

    Nuclear chromatin pattern

  • 38

    MATURATION STORAGE % metamyelocytes

    45

  • 39

    MATURATION STORAGE 45%

    metamyelocytes

  • 40

    MATURATION STORAGE 35%

    BAND FORM NEUTROPHILS

  • 41

    MATURATION STORAGE % BAND FORM NEUTROPHILS

    35

  • 42

    MATURATION STORAGE 20%

    SEGMENTED NEUTROPHILS

  • 43

    MATURATION STORAGE % SEGMENTED NEUTROPHILS

    20

  • 44

    myelocytes DAYS

    4.3 DAYS

  • 45

    4.3 DAYS

    myelocytes

  • 46

    15 HOURS

    MYELOBLASTS

  • 47

    MYELOBLASTS TIME

    15 HOURS

  • 48

    24 HOURS

    PROMYELOCYTES

  • 49

    PROMYELOCYTES HOURS

    24

  • 50

    % PROGENITOR CELLS

    0.1- 0.2

  • 51

    0.1- 0.2% ? CELLS

    PROGENITOR CELLS

  • 52

    1% ?

    MYELOBLASTS

  • 53

    % MYELOBLASTS

    1

  • 54

    3%

    PROMYELOCYTES

  • 55

    ?% PROMYELOCYTES

    3

  • 56

    -Spongy/foamy cytoplasm

    Myeloblast

  • 57

    Myeloblast -appearance? cytoplasm

    Spongy/foamy

  • 58

    --sieve-like nucleus

    Myeloblast

  • 59

    Myeloblast --?-like nucleus

    sieve

  • 60

    Contains primary specific granules

    Promyelocyte

  • 61

    Promyelocyte Contains ? specific granules

    primary

  • 62

    Lymphocytes don’t have ______

    Myeloperoxidase

  • 63

    ? don’t have Myeloperoxidase

    Lymphocytes

  • 64

    Secondary granules

    Myelocyte

  • 65

    Myelocyte ? granules

    Secondary

  • 66

    -1st stage where granulocytes can be differentiated

    Myelocyte

  • 67

    Once the metamyelocyte stage has been reached, cells have undergone _____ division the the proliferation phase comes to an end

    4 or 5

  • 68

    Once the ? stage has been reached, cells have undergone 4 or 5 division the the proliferation phase comes to an end

    metamyelocyte

  • 69

    -Predominant WBC precursor in the bone marrow

    Metamyelocyte/Juvenile cells

  • 70

    Metamyelocyte/? cells

    Juvenile

  • 71

    /Juvenile cells

    Metamyelocyte

  • 72

    -Tertiary granules

    Metamyelocyte/Juvenile cells

  • 73

    Metamyelocyte/Juvenile cells -? granules

    Tertiary

  • 74

    First immature WBC seen in the blood

    Band cell

  • 75

    Basophil stay in the maturation-storage phase for ____ hrs

    12

  • 76

    ? stay in the maturation-storage phase for 12 hrs

    Basophil

  • 77

    is a hallmark of allergic disorders

    eosinophilia

  • 78

    eosinophilia is a hallmark of ? disorders

    allergic

  • 79

    Not true WBC

    Mast cell

  • 80

    cells in Humoral immunity

    B cell

  • 81

    B celL ? immunity

    Humoral

  • 82

    Cellular immunity

    T and Nk Cell

  • 83

    ? immunity : T and Nk Cell

    Cellular

  • 84

    B cells with hair like projection which are identified by being TRAP resistance

    Hairy cell

  • 85

    Hairy cell : B cells with hair like projection which are identified by being ? resistance

    TRAP

  • 86

    Mononuclear cell with a cerebriform nucleus

    Sezary cell

  • 87

    Deeply basophilic cytoplasm with eccentric nucleus

    Plasma cell

  • 88

    Hyposegmentation/

    Pelger-huet

  • 89

    pince nez

    Pelger-huet

  • 90

    dumb bell

    Pelger-huet

  • 91

    peanut shape

    Pelger-huet

  • 92

    spectacle like

    Pelger-huet

  • 93

    Large platelet with Dohle-like

    May heglin

  • 94

    May heglin ? platelet with Dohle-like

    Large

  • 95

    May heglin : Large platelet with ? -like

    Dohle

  • 96

    Increased LAP score

    Leukemoid reaction

  • 97

    Leukemoid reaction ? LAP score

    Increased

  • 98

    Markedly decreased LAP

    CML

  • 99

    CML Markedly ? LAP

    decreased

  • 100

    There is a relative ? in children from ages 4 months to 4 years Because of this, the percentage of lymphocytes is increased in this population. This is commonly referred to as a reversal in the normal differential percentage (or inverted differential)

    neutropenia